M5A

Copper-64 labeled anti-CEA monoclonal antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M5A, covering 2023-04-21 to 2023-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]